Published: Mon, 16 Aug 2010 13:52:48 GMT
Updated: Tue, 10 Apr 2012 10:32:08 GMT
All programme activities funded by the Unit for Research Cooperation must be carried out in compliance with fundamental ethical principles as outlined below. It is the responsibility of each applicant to ensure compliance with international conventions and declarations on ethical considerations and intellectual property rights.
The following section outlines the guidelines for
organisations applying for regional and
international research support from the Unit for Research
Cooperation.
1) Ethical approval of medical or health research
projects is required as follows:
For projects carried out in their entirety in Sweden, Swedish
regulations shall apply. For projects carried out in other
countries the following rules shall apply:
Projects involving human subjects require ethical approval by a
responsible authority in the country concerned. Where Swedish
researchers or institutions participate, approval is also required
from a Swedish ethical committee.
Projects involving clinical trials of drugs, vaccines or other
pharmaceutical preparations require, in addition, approval by a
drug regulatory authority or other responsible authority in the
country concerned. Where Swedish researchers/institutions
participate or Swedish products are tested, approval shall also be
obtained from the Medical Products Agency (Läkemedelsverket) in
Sweden.
Projects involving experiments with animals should, whenever
possible, be approved by a responsible authority in the country
concerned. Where Swedish researchers or institutions participate,
approval is also required from a Swedish ethical committee for
animal experiments.
When changes or additions are made to the original project plan
renewed ethical approval is required.
The recipient scientist/institution is responsible for ensuring
that ethical approval in accordance with the above-mentioned rules
is obtained before the study is started. Sida retains the right to
require that the recipient scientist/institution produce proof of
ethical approval before the grant is disbursed.
2) Intellectual Property Rights
As regards patents and know-how the participating Swedish and
collaborating country institutions and researchers co-operating in
the research project shall have access to all results and know-how
obtained within the collaborative projects mentioned in the
Agreement. Each party that has participated in the co-operation
shall have the right to the patent in their own name and at their
own expense.
The registration fees for the patent in Sweden and collaborating
country shall be divided equally between the participating
institutions. The participating institutions shall decide whether
or not the patent is to be registered in a third country.
Should UNIV/INST choose not to exercise its right to apply for a
patent, the other institutions are to be given the option to do so
in their own name and at their own expenses.
The participating institutions shall have the right to equal
shares of the revenue derived from grant of user licences to third
parties if the patent is registered by mutual Agreement. The grant
of user licences and patent(s) shall be determined in each case by
mutual Agreement between the participating institutions provided
the participating institutions provided the participating
institutions agree in delegating such a task to one party.
Print page